TransHeps specializes in iDILI causality assessments, supporting drug developers in clinical trials and managing drug-induced liver injuries. Leveraging cutting-edge expertise, we provide reliable solutions to improve drug safety and accelerate pharmaceutical innovations.
Some insights
TransHeps' team excels in liver toxicology, cell culture assays, and operational leadership, with strong expertise in pharma, biotech, and commercialization. We aim to integrate advanced business development, AI-driven analytics, and clinical trial expertise to expand our global impact.